Bliss GVS Pharma Limited

NSE:BLISSGVS.NS

158.66 (INR) • At close September 3, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202520242023202220212020201920182017201620152014201320122011201020092008200720062005
Operating Activities:
Net Income 842.993754.5411,060.7161,277.5981,041.271,289.6511,819.131,794.9061,791.791,481.947960.192705.5821,094.824794.193529.814457.552402.535352.31958.63711.8124.237
Depreciation & Amortization 294.176263.798186.733173.308172.297125.89189.435213.829205.511142.511122.872112.07361.24436.46154.69554.01135.91429.26629.171.2440.746
Deferred Income Tax 00-182.667-141.05-70.9030000000000000000
Stock Based Compensation 41.438.15739.04357.07798.3760000000000000000
Change In Working Capital -622.94130.416-851.191733.725-578.862-692.216-1,830.727-1,407.9781,134.843-83.269-609.365218.568-745.703-378.301-216.257-395.866-234.859-390.762-81.108-13.1381.969
Accounts Receivables -446.544-445.187-149.981512.907629.256-785.311-1,821.681-370.653975.162-534.635-324.436296.185-1,288.985000000-13.1281.407
Inventory -304.542-224.218150.032-290.968-268.0118.055-183.339-93.383-109.289-49.73-11.696-0.072-198.424-10.69190.61680.198-195.661-157.218-6.6740.913-0.364
Accounts Payables 108.38-251.003-63.16183.443-146.762128.413205.156-398.128-0.8960000000000-0.9230.926
Other Working Capital 128.145950.824-788.082328.343-793.345-43.373-30.863-1,314.5951,244.132-33.539-597.669218.64-547.279-367.611-406.873-476.064-39.198-233.544-74.43400
Other Non Cash Items 503.501437.57490.501-745.852-22.484-270.53321.662-424.364-253.58-411.72415.671-213.095-351.646-88.567-131.677-46.736-20.455-0.604-2.2252.9420.356
Operating Cash Flow 1,059.1291,524.486343.1351,354.806639.694452.796399.5176.3932,878.5641,129.465489.37823.12858.719363.786236.57568.961183.135-9.7814.4742.867.308
Investing Activities:
Investments In Property Plant And Equipment -760.653-283.293-937.99-740.031-91.242-603.149-437.685-282.172-1,517.627-133.093-396.031-574.091-192.046-232.548-105.086-45.214-133.898-20.747-27.391-12.011-7.611
Acquisitions Net 34.1210139.25110.6794.2068.55657.48-210.0330.16.54400-1,088.33600000000
Purchases Of Investments -585.547-1,152.102-77.073-22.308-436.889-32.219-396.8210-547.818-1.00100-0.1-9.2270000000
Sales Maturities Of Investments 395.31451.0622.495-10.679432.68323.663339.341601.0950.10007.26300000000
Other Investing Activites 162.35656.117775.808-167.412-378.668113.66-297.501242.509-794.937-380.5466.21653.43432.71822.6437.1576.790.2010.7650.90700
Investing Cash Flow -754.409-1,328.218-77.509-929.751-469.91-489.489-735.186561.432-2,312.464-514.64-389.815-520.657-1,240.501-219.132-97.929-38.424-133.697-19.982-26.484-12.011-7.611
Financing Activities:
Debt Repayment -164.736-88.958-138.732-156.057-89.288110.777266.22-196.649-65.314-190.154-102.877250.6941,157.491368.8475.97322.771-10.80869.749-14.5893.625-0.174
Common Stock Issued 28.86223.1420.41522.84400000000000000000
Common Stock Repurchased 000000000000000000000
Dividends Paid -54.487-53.949-54.372-53.265-55.495-125-82.374-74.494-62.722-61.561-86.273-48.897-82.49-78.2-96.539-18.101-7.542-7.378-4.1510-2.94
Other Financing Activities -113.085-89.163-76.696-50.823-63.197-24.046-15.534-488.6126.775-150.794-230.648-36.75723.907-25.869-21.4730-22.619-13.834-6.66200
Financing Cash Flow -303.446-208.93-249.385-237.301-207.98-38.269168.312-759.753-240.514-386.31-432.639-2.251,098.908255.572-112.039-15.772-40.96948.537-25.4023.625-3.114
Other Information:
Effect Of Forex Changes On Cash 0.987-1.50113.957-99.22816.14677.466-51.729-23.62-150.073-3.4430.0010000.00169.9680084.4800
Net Change In Cash 2.261-14.16330.19888.526-22.053.032-219.103-45.548175.513225.072-333.083300.221-82.874400.22626.60884.7338.46918.77437.06800
Cash At End Of Period 238.167235.906250.069219.871131.345153.425150.393428.571451.493275.98162.598803.721497.182580.056179.83153.22268.48960.0241.2461.7062.081